arrow
N

Nandakumar Packiriswamy

Mayo Clinic
H指数:14
被引数:659

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase I trial of intravenous vesicular stomatitis virus expressing thyroidal sodium iodide symporter (NIS) and human interferon beta (hIFNβ) in metastatic or recurrent endometrial cancer

静脉注射表达甲状腺钠碘 symporter(NIS)和人类干扰素β(hIFNβ)的vesicular stomatitis virus 在转移性或复发性子宫内膜癌中的I期临床试验

2026-11-050
PRE
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity
MBIO
IF4.7
2024-02-142
OAAI
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses
2023-10-317
OAAI
Phase I trial of vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 (VSV-IFNb-TYRP1) in metastatic ocular melanoma
2023-04-141
PRE
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphoma

复发难治性T细胞淋巴瘤患者单剂量全身溶瘤VSV病毒治疗的临床活性

2022-02-1727
OAAI
Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma
2021-12-010
PRE
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination
2019-09-0110
OAAI